Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VLA1553 controlled human infection model establishment study in healthy volunteers
NL-OMON57290Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of fezolinetant in Chikungunya (CHIKV), sponsored by Centre for Human Drug Research. Primary endpoints: Infection rate and Symptomatic rate. Started Mar 2025; status: completed.
02
Drugs
fezolinetant
03
Conditions
Chikungunya (CHIKV)
Beyond the preview
Go deeper on NL-OMON57290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON57290.